MX382985B - Nuevos virus de tilapia y sus usos - Google Patents

Nuevos virus de tilapia y sus usos

Info

Publication number
MX382985B
MX382985B MX2018013582A MX2018013582A MX382985B MX 382985 B MX382985 B MX 382985B MX 2018013582 A MX2018013582 A MX 2018013582A MX 2018013582 A MX2018013582 A MX 2018013582A MX 382985 B MX382985 B MX 382985B
Authority
MX
Mexico
Prior art keywords
tilv
polypeptides
animal
viruses
nucleic acids
Prior art date
Application number
MX2018013582A
Other languages
English (en)
Inventor
Avi Eldar
Eran Bacharach
Nischay Mishra
Thomas Briese
W Ian Lipkin
Original Assignee
Univ Columbia
Kimron Veterinary Inst
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia, Kimron Veterinary Inst, Univ Ramot filed Critical Univ Columbia
Publication of MX382985B publication Critical patent/MX382985B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere al Virus de la Tilapia del Lago aislado o TiLV, y las secuencias y polipéptidos de 5 ácido nucleico aislado del mismo. La invención también se refiere a sondas y cebadores, y a anticuerpos contra antígenos del TiLV, y el uso de estos reactivos para detectar la presencia o ausencia de TiLV en un animal. La invención también se refiere a ARNis que se dirigen a 10 secuencias de ácido nucleico de TiLV. La invención también se refiere a composiciones inmunogénicas, incluyendo anticuerpos y vacunas, para inducir una respuesta inmune contra TiLV en un animal. La invención también se refiere a construcciones genéticas y células que comprenden TiLV y 15 secuencias de ácidos nucleicos aislados y polipéptidos de las mismas para su uso en el desarrollo de agentes profilácticos y terapéuticos.
MX2018013582A 2014-12-15 2015-12-15 Nuevos virus de tilapia y sus usos MX382985B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462091824P 2014-12-15 2014-12-15
PCT/US2015/065795 WO2016100328A1 (en) 2014-12-15 2015-12-15 Novel tilapia virus and uses thereof

Publications (1)

Publication Number Publication Date
MX382985B true MX382985B (es) 2025-03-13

Family

ID=56127461

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2018013582A MX382985B (es) 2014-12-15 2015-12-15 Nuevos virus de tilapia y sus usos
MX2017007876A MX371220B (es) 2014-12-15 2015-12-15 Nuevos virus de tilapia y sus usos.
MX2021002525A MX392857B (es) 2014-12-15 2017-06-14 Nuevos virus de tilapia y sus usos.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2017007876A MX371220B (es) 2014-12-15 2015-12-15 Nuevos virus de tilapia y sus usos.
MX2021002525A MX392857B (es) 2014-12-15 2017-06-14 Nuevos virus de tilapia y sus usos.

Country Status (12)

Country Link
US (4) US10183072B2 (es)
CN (2) CN107427570A (es)
BR (1) BR112017012852A2 (es)
CO (1) CO2017007105A2 (es)
CR (1) CR20210528A (es)
EC (1) ECSP17045428A (es)
HK (1) HK1244700A1 (es)
IL (3) IL266234B2 (es)
MX (3) MX382985B (es)
MY (3) MY176597A (es)
SG (3) SG10201901053TA (es)
WO (1) WO2016100328A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
EP3400007A4 (en) * 2016-01-10 2019-08-28 Abic Biological Laboratories Ltd. ORTHOMYXO-LIKE VIRUS OF THE BUNTBARSCH
CN108018377B (zh) * 2017-12-07 2021-07-20 中国水产科学研究院珠江水产研究所 一种罗湖病毒的rt-lamp检测引物组、试剂盒及方法
CN108018378A (zh) * 2017-12-11 2018-05-11 中国水产科学研究院珠江水产研究所 一种罗湖病毒Taq-man探针荧光定量PCR检测试剂盒及检测方法
CN108192869A (zh) * 2018-01-24 2018-06-22 武汉轻工大学 一种斑点叉尾鮰头肾巨噬细胞原代分离培养方法及应用
CN108220483A (zh) * 2018-02-12 2018-06-29 深圳出入境检验检疫局动植物检验检疫技术中心 一种用于罗非鱼湖病毒检测的试剂、检测方法及应用
CN109234451B (zh) * 2018-09-26 2021-04-16 中国水产科学研究院长江水产研究所 一种罗非鱼细小病毒TiPV CPA检测引物及应用
CN109852588B (zh) * 2018-12-24 2023-03-07 中国水产科学研究院珠江水产研究所 一种抗罗非鱼免疫球蛋白IgM的单克隆抗体及其细胞株和应用
CN110616281A (zh) * 2019-10-29 2019-12-27 周伟光 一种应用实时荧光rt-pcr定量检测罗湖病毒的方法
CN111436390B (zh) * 2020-04-20 2021-11-16 中国热带农业科学院热带生物技术研究所 一种降低TiLV对罗非鱼致死率的温度调控养殖系统及方法
CN113122510A (zh) * 2021-04-12 2021-07-16 中国水产科学研究院黑龙江水产研究所 一种传染性造血器官坏死病疫苗及其病毒在胖头鱥肌肉细胞上扩增的方法
CN113718061B (zh) * 2021-09-30 2023-06-09 厦门海关技术中心 一种同时检测罗湖病毒和病毒性神经坏死病毒的双重rt-pcr的引物组，试剂盒和方法
CN113755645B (zh) * 2021-09-30 2023-06-09 厦门海关技术中心 一种检测罗湖病毒的荧光定量rt-pcr引物对和探针，试剂盒和检测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737730B1 (fr) 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
WO2003017780A1 (en) * 2001-08-27 2003-03-06 Advanced Bionutrition Corporation Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
AU2002233969A1 (en) * 2001-12-07 2003-06-23 Schweitzer Chemical Corporation Usa Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
US8796436B2 (en) 2003-04-17 2014-08-05 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
US20090149641A1 (en) * 2007-03-07 2009-06-11 Nofima Akvaforsk-Fiskeriforskning As Fish disease protection
EP2482824B1 (en) * 2009-10-02 2016-11-30 The Trustees of Columbia University in the City of New York Piscine reovirus immunogenic compositions
CN104884084B (zh) * 2012-09-26 2018-05-22 Fvg有限公司 鱼用亚单位浸泡疫苗
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines

Also Published As

Publication number Publication date
US20180369360A1 (en) 2018-12-27
US20200254084A1 (en) 2020-08-13
SG11201704887SA (en) 2017-07-28
IL266234B2 (en) 2025-10-01
WO2016100328A8 (en) 2017-01-19
CR20210528A (es) 2021-12-06
IL286265B1 (en) 2024-10-01
WO2016100328A1 (en) 2016-06-23
US11583579B2 (en) 2023-02-21
IL252919A0 (en) 2017-08-31
IL252919B (en) 2022-07-01
BR112017012852A2 (pt) 2018-01-09
CO2017007105A2 (es) 2018-01-05
MX392857B (es) 2025-03-24
MY176597A (en) 2020-08-18
SG10201901053TA (en) 2019-03-28
IL286265A (en) 2021-10-31
HK1244700A1 (zh) 2018-08-17
MX2017007876A (es) 2018-11-09
MX371220B (es) 2020-01-08
US10596249B2 (en) 2020-03-24
SG10202102695UA (en) 2021-04-29
ECSP17045428A (es) 2018-07-31
MX2021002525A (es) 2022-06-02
MY192642A (en) 2022-08-29
CN107427570A (zh) 2017-12-01
US10183072B2 (en) 2019-01-22
CN114057841A (zh) 2022-02-18
US10973902B2 (en) 2021-04-13
US20170360918A1 (en) 2017-12-21
IL266234B1 (en) 2025-06-01
US20210205437A1 (en) 2021-07-08
MY208671A (en) 2025-05-23
IL266234A (en) 2019-06-30
IL286265B2 (en) 2025-02-01

Similar Documents

Publication Publication Date Title
MX382985B (es) Nuevos virus de tilapia y sus usos
CY1124867T1 (el) Αντισωματα μονης περιοχης που κατευθυνονται εναντι ενδοκυτταρικων αντιγονων
EA201391109A1 (ru) Молекулы нуклеиновой кислоты, кодирующие новые антигены герпеса, вакцина, включающая их, и способы их использования
EA201891712A2 (ru) Молекулы нуклеиновых кислот гриппа и вакцины, изготовленные из них
EA202090759A3 (ru) Коровый белок вируса гепатита в и поверхностный антигенный белок и содержащая их вакцина
BR112019005511A2 (pt) vetores de adenovírus canino
MX383506B (es) Parvovirus porcino.
CY1124388T1 (el) Εμβολιο για ανοσοεξασθενημενους δεκτες
BR112018008840A8 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
PH12017501100B1 (en) Recombinant swinepox virus and vaccines
WO2016022958A3 (en) Tick-associated virus sequences and uses thereof
CY1125328T1 (el) Ανασυνδυασμενο εμβολιο ιου λευχαιμιας αιλουροειδων περιεχοντας βελτιστοποιημενο γονιδιο φακελου ιου λευχαιμιας αιλουροειδων
AR110626A1 (es) Paramixovirus y sus usos
WO2011041788A3 (en) Turkey viral hepatitis virus and uses thereof
MX361804B (es) Vacunas genéticas contra el virus hendra y el virus nipah.
WO2016061210A3 (en) Novel viruses found in rattus norvegicus and uses thereof
RU2016147543A (ru) Способ применения ДНК-вакцинного вектора, созданного на основе кодон-оптимизированного гена гликопротеина (белкаG) вируса бешенства, для профилактики бешенства
TH176276A (th) พอซีนพาโวไวรัส 5b, วิธีการใช้และวัคซีน
AR102610A1 (es) Anticuerpos anti interleuquina 33 y sus usos
MX2018013358A (es) Vacunas para el virus del papiloma humano y metodos para su uso.